Stephanie Graff: Polygenic Risk Score in Breast Cancer Risk Assessment
Stephanie Graff, Director of the Breast Oncology Program at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University, shared on X:
“Polygenic Risk Score (CRS) in Breast Cancer Risk Assessment
CRS predicted a different risk level than Tyrer-Cuzick (TC) for a substantial proportion of patients
CRS+ and/or TC+ received high-risk screening c/w guidelines for TC+ (recommendations for CRS+ do not exist).”
Stephanie L. Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University and co-leader of the Breast Cancer Translational Research Disease Group. She is an Associate Professor of Medicine at the Warren-Alpert School of Medicine. She also serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research, is an Associate Editor of Cancer Medicine, and chairs the editorial board of Oncology Times. Dr. Graff has received the Frist Humanitarian Award for her work in the community, Healio® Disruptive Innovator Woman Disruptor of Year in 2022, and the RI American College of Physicians’ Benjamin L. Sapers Memorial Award for her “passion for pedagogy, academic rigor, empathy and humanism.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023